Sectors
Digital health in the region combines access, financing and technology: memberships and coverage, telemedicine, pharmacy and clinical software. Investors value patient retention, relationships with providers and insurers, and regulatory compliance. We work at the border between healthtech and insurtech, as in Mutuus’s round, and have in-house sector analysis capability.
Investors are funds with health and inclusion theses, and corporate vehicles of insurers, pharmaceutical companies and hospital groups. Strategic buyers are hospital and laboratory groups, insurers and regional health platforms integrating digital channels.
Capital, debt and M&A in the sector, with public sources cited.
Research
Andreessen Horowitz, Sierra Ventures and Kfund led rounds of USD 22 to 33 million in 2025 and 2026, strategic buyers acquire home care and hospital management, and digital health is now written into law.
Listed comparable companies in the sector: price, market value, multiples and expected growth. Data as of 31 August 2026.
Analyses of recent deals in the sector: structure, value drivers and what they signal to the market.
Deal analysis
An artificial-intelligence platform that validates healthcare claims and authorisations, with more than USD 25 billion processed, raises capital for infrastructure, product and acquisitions after growing revenue and clients fourfold in a year.
Deal analysis
A Mexican cloud RIS/PACS platform with more than 2,200 institutions and 13 million studies a year raises capital from a Silicon Valley fund and a Mexican business leader to go to Colombia and the United States.
Deal analysis
Mexico’s leading major medical insurer becomes a minority shareholder in a digital network of hospitals, specialists and laboratories; the percentage and the valuation were not disclosed.
Deal analysis
A home-hospital operator, profitable since 2024 and contracted with more than 25 health plans, raises development-finance capital to acquire traditional home-care providers and enter Rio de Janeiro.
Deal analysis
A Mexican healthtech with an insured book buys in-home operating capacity rather than building it; the price was not disclosed, but claims cost and readmissions explain the deal.
Deal analysis
An AI platform that already resolves 75% of interactions across 90 institutions in Mexico, Colombia and Costa Rica raises capital from a Mexican fund to grow across the region.
Deal analysis
A Series A-sized seed for an AI copilot that runs on WhatsApp, with a team of 13; what is being paid for is the founder, the channel and the speed of deployment across 14 countries.
Deal analysis
An electronic-prescription platform controlled by DNA Capital since 2021, at breakeven since June 2025 and projecting BRL 100 million in 2026 revenue, takes capital from two new funds to bring artificial intelligence to the prescription.
Deal analysis
The Brazilian digital-prescription platform has raised BRL 340 million across eight rounds, priced the extension above its 2024 round and runs the business on a pharmacy marketplace connected to 100,000 active doctors.
Deal analysis
An artificial-intelligence platform for hospital revenue cycle, serving more than 60 hospitals and four of the ten largest networks in Brazil, raises a Series A-sized seed after growing more than 20 times in 2025.
Deal analysis
An AI-native clinical platform with 14 million patients and 25 hospital systems across five countries, Mexico included, raises USD 42 million in under a year since launch.
Every initial conversation is confidential and handled directly by a partner. We reply within two business days.
